|Day Low/High||2.45 / 2.54|
|52 Wk Low/High||2.00 / 7.15|
Recently Completed Refinancing Transactions to Provide Company with up to $45 Million in Aggregate New Capital to Grow Company's Business
Transactions will Provide up to $45 Million in Aggregate New Capital to Grow Company's Business
Company Expects to Report Full Quarterly Financial Results and Host Conference Call on July 27, 2017
First Quarter Prescription Volumes Grew Year-Over-Year for Zohydro ER® with BeadTek™ and Silenor®
Fourth Quarter Prescription Volumes Grew Year-Over-Year for All Three Core Brands, Treximet®, Zohydro ER® with BeadTek™ and Silenor®
Regains Compliance with NASDAQ Listing Rule 5605(c)(2)(A)
Company to Begin Focused Product Promotion Activities in Early Q4 2016
Patents cover important safety information related to dosing patients
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.